Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 20 for “"B형 간염"”.

  1. Efficacy of Entecavir in Patients with Hepatitis B virus-Related Decompensated Liver Cirrhosis

    "배경/목적: 엔테카비어는 강력한 항 바이러스 효과와 적은 내성 발생률로 만성 B형 간염 환자에서 치료제로 사용되고 있다. 엔테카비어는 비대상 간경변 환자들에게도 안전하게 사용될 수 있는 치료제로 추천되나, 비대상 간경변 환자에서 치료 효과에 대한 연구보고는 드물다. 이에 저자들은 B형 간염에 의한 비대상 간경변 환자를 대상으로 엔테카비어 치료 효과를 알아보고자 하였다. 연구대상 및 방법: 2006년 11월부터 2009년 9월까지 아주대학교 병원에 내원한 만성 B형 간염으로 인한 비대상 간경변 환자 중 6개월 이상 …

    ajou Repository record for Efficacy of Entecavir in Patients with Hepatitis B virus-Related Decompensated Liver Cirrhosis (opens in a new tab)

  2. Analysis of Treatment Effect of Lamivudine plus Adefovir Add-on Therapy in Patients with Lamivudine Resistant Chronic B-viral Hepatitis

    목적: 라미부딘은 만성 B형 간염의 1차 치료제로 널리 사용되어 왔으나 내성 발현이 잦은 단점이 있다. 이러한 단점을 극복하기 위해 아데포비어 병합 치료가 사용되고 있으나 한국인을 대상으로 한 연구 결과는 적은 편이다. 저자들은 라미부딘에 내성인 B형 만성 간염 환자를 대상으로 라미부딘과 아데포비어 병합 치료 효과와 바이러스 돌파 현상을 확인하고자 하였다. 방법: 2005년 8월부터 2010년 10월까지 본원에서 라미부딘 투여 중 내성이 발생한 후 아데포비어를 추가??여 치료한 환자 중 12개월 이상 치료받은 93명을 대상으로 …

    ajou Repository record for Analysis of Treatment Effect of Lamivudine plus Adefovir Add-on Therapy in Patients with Lamivudine Resistant Chronic B-viral Hepatitis (opens in a new tab)

  3. Entecavir Therapy for Patients with Hepatitis B Virus-Related Decompensated Cirrhosis

    … 환자에서 엔테카비어의 장기 치료 효과에 대한 연구 결과는 많지 않다. 이에 저자들은 B형 간염 바이러스에 의한 비대상성 간경변환자를 대상으로 엔테카비어 치료 효과와 엔테카비어 효과를 예측할 수 있는 인자를 알아보고자 하였다. 대상 및 방법: 2006년 11월부터 2011년 1월까지 아주대학교 병원에 내원한 만성 B형 간염으로 인한 비대상성 간경변 환자 중 6개월이상 엔테카비어 치료를 받은 45명을 후향적으로 조사하였다. 대상 환자는 전 예에서 HBV DNA양성이고 Child-Pugh score가 8점 이상이며, HBeAg은 …

    ajou Repository record for Entecavir Therapy for Patients with Hepatitis B Virus-Related Decompensated Cirrhosis (opens in a new tab)

  4. AMP-activated protein kinase-mTOR signaling pathway and hepatitis B virus replication

    B형간염 바이러스(hepatitis B virus, HBV)는 Hepadnaviridae family에 속하며, genome 크기가 약 3.2kb의 작은 DNA 바이러스이다. 전 세계적으로 약 3억 5천만 명 이상이 만성으로 HBV에 감염되어 있다. HBV는 급성과 만성 B형 간염을 일으키며 만성 B형 간염 환자는 간경변이나 간암으로 발전할 가능성이 높다. AMP-activated protein kinase(AMPK)는 ATP 소비와 생성의 균형을 위해서 필요한 에너지 센서 단백질이다. Hepatitis C virus(HCV)의 …

    ajou Repository record for AMP-activated protein kinase-mTOR signaling pathway and hepatitis B virus replication (opens in a new tab)

  5. Factor Analysis for enhancing infection preventing performance level of Dental Hygienist

    … 감염성 질환에 감염된 경험이 있는 대상자는 6명(3.6%)이었다. 감염된 질환은 “B형 간염”이 4명으로 가장 많았고, “풍진” 1명, “결핵” 1명이었다. 2) 일반적 특성 실천도 분석 결과, 연령(F=3.237, p=0.024)과 근무 경력(F=3.333, p=0.021)에서 유의한 실천도 점수의 차이가 있었다. 교육경험 여부는 근무처(X²=19.823, p=0.001)에 따라, 지식도는 연령(F=4.895, p=0.003)에 따라 통계적으로 유의한 차이를 보였다. 감염예방 교육경험이 있는 경우가 경험이 없는 경우에 …

    ajou Repository record for Factor Analysis for enhancing infection preventing performance level of Dental Hygienist (opens in a new tab)

  6. Critical C-termical Amino Acids of Hepatitis B Virus Core Proteins for HBV Replication

    B형 간염 바이러스는 Hepadnaviridae Family로써, 크기가 3.2kb인 partieally duplex DNA genome을 가지고 있으며, 4개의 open reading frame (ORF)으로부터 core protein, surface protein, DNA polymerase, X protein을 발현한다. HBV core protein은 183개 또는 185개의 amino acid로 구성되어있는 22kDa의 단백질이며, HBV core protein은 pgRNA 의 encapsidation 및 DNA 합성에 …

    ajou Repository record for Critical C-termical Amino Acids of Hepatitis B Virus Core Proteins for HBV Replication (opens in a new tab)

  7. Analysis of Treatment Effect of Lamivudine, Adefovir Add-on Therapy in Patients with Lamivudine Resistant Chronic B-viral Hepatitis

    Background: Add on adefovir (ADV) to ongoing lamivudine (LAM) is an established treatment modality for treatment of LAM resistance with chronic hepatitis B. We assessed the long?term efficacy (median follow-up of 20.18 months) of ADV add-on LAM therapy in 89 LAM-resistant patients. Methods: 89 …

    ajou Repository record for Analysis of Treatment Effect of Lamivudine, Adefovir Add-on Therapy in Patients with Lamivudine Resistant Chronic B-viral Hepatitis (opens in a new tab)

  8. Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine resistant chronic hepatitis B patients

    BACKGROUNDS: Adefovir dipivoxil effectively inhibits both wild-type and lamivudine-resistant hepatitis B virus replication. The development of adefovir resistance is delayed and infrequent compared with lamivudine resistance. The aim of this study was to characterize the serologic, biochemical and …

    ajou Repository record for Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine resistant chronic hepatitis B patients (opens in a new tab)

  9. Association of Interleukin-12 gene polymorphism with Hepatitis B virus persistnece and Hepatocelluar carcinoma

    BACKGROUND: Infection with hepatitis B virus (HBV) may result in various conditions. Natural course of HBV infection may result from host immune factors including single nucleotide polymorphisms(SNPs), and cytokines play a crucial role in host immune defense. This study was undertaken to …

    ajou Repository record for Association of Interleukin-12 gene polymorphism with Hepatitis B virus persistnece and Hepatocelluar carcinoma (opens in a new tab)

  10. Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients

    BACKGROUND: Relapse has been reported after stopping Nucleos(t)ide (NUC) therapy in the majority of chronic HBeAg negative hepatitis patients. However, the ideal treatment duration of HBeAg negative chronic hepatitis B (CHB) is not well known. We investigate the frequency of relapse rate in HBeAg …

    ajou Repository record for Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients (opens in a new tab)

  11. Functional Role of Hepatitis B Virus Core Protein in Viral Replication

    PART I To investigate the contributions of carboxyl-terminal nucleic acid binding domain of HBV core protein for hepatitis B virus (HBV) replication, chimeric HBV core proteins were generated by substituting varying lengths of the carboxyl-terminus of duck hepatitis B virus (DHBV) core protein for …

    ajou Repository record for Functional Role of Hepatitis B Virus Core Protein in Viral Replication (opens in a new tab)

  12. The Intracellular Changes and the Localization of Core particles by Hepatitis B Virus P Protein-Deficient Mutant

    PURPOSE: Hepatitis B virus (HBV) core particles move to ER or recycle back to the nucleus. This moving mechanism is thought to be important in HBV replication and HBV life cycles. P protein-deficient mutant can form core particles in the absence of P protein and pregenomic RNA (pgRNA). In this …

    ajou Repository record for The Intracellular Changes and the Localization of Core particles by Hepatitis B Virus P Protein-Deficient Mutant (opens in a new tab)

  13. C-terminus of Hepatitis B virus RNase H Domain is Important for HBV replication

    Hepatitis B Virus (HBV) DNA polymerase (P) protein consisting of terminal protein (TP), spacer, reverse transcriptase (RT), and RNase H, plays critical roles in viral assembly and replication. RNase H domain is required for HBV DNA replication, however critical motif or amino acid residues in the …

    ajou Repository record for C-terminus of Hepatitis B virus RNase H Domain is Important for HBV replication (opens in a new tab)

  14. Relationship between Hepatitis B Virus Core Particles and Intracellular Motility

    PURPOSE: Hepatitis B virus (HBV) core particles recycle back to the nucleus. This recycling mechanism is thought to be important in maintaining covalently closed circular (cccDNA) pool in the nucleus. Transport of HBV core particles in host cytoplasm is important for HBV life cycle but the …

    ajou Repository record for Relationship between Hepatitis B Virus Core Particles and Intracellular Motility (opens in a new tab)

  15. Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection

    BACKGROUND: The differential diagnosis between inactive carrier and active hepatitis is important in patients with chronic hepatitis B (CHB) virus infection. Serum cytokeratin (CK)-18 fragments (M30 antigen) are proposed as biomarkers of apoptosis. We investigated whether serum M30 levels might …

    ajou Repository record for Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection (opens in a new tab)

  16. Serum markers for predicting significant necroinflammatory activity in patients with chronic hepatitis B

    OBJECTIVES: The aim of this study was to determine the serum markers that predict significant inflammation in patients with chronic hepatitis B (CHB). DESIGN AND METHODS: Between October 2005 and June 2009, 384 subjects with CHB were enrolled. RESULTS: Multiple logistic regression analysis …

    ajou Repository record for Serum markers for predicting significant necroinflammatory activity in patients with chronic hepatitis B (opens in a new tab)

  17. Initial Stages of Hepatitis B Virus Replication

    PART 1 Intracellular Trafficking of HBV Core Particle in Various Stage of DNA Replication Inside of hepatitis B virus (HBV) core particle, pgRNA is reverse transcribed by HBV DNA polymerase into minus-strand DNA and pregenomic RNA (pgRNA) is degraded concomitantly by RNase H activity of DNA …

    ajou Repository record for Initial Stages of Hepatitis B Virus Replication (opens in a new tab)